U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07152431) titled 'Fibrosis Associated Protein Inhibitor (FAPI) Radiotracer-based Imaging to Identify Fibrotic... Read More
U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07151170) titled 'Telerehabilitation Versus Supervised Pelvic Floor Muscle Training in Urinary Incontinence' ... Read More
U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07152197) titled 'Effects of Resistance Exercises in Hereditary Sensory-Motor Neuropathy (Charcot-Marie-Tooth... Read More
U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07152574) titled 'ROTAO 1 - Feasibility and Safety of the TAVIPILOT Tele-operated Robot During Transcatheter ... Read More
U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07153224) titled 'Mentorship, Intraoperative Consultation, and Coaching for Resilience and Outcomes in Early-... Read More
U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07152457) titled 'Emergency Room Analgesia and Sedation Survey-2' on Aug. 26. Brief Summary: Part 1: Assessm... Read More
U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07152873) titled 'A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A' on... Read More
U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07153237) titled 'Clinical Performance and Safety of STYLAGE(R) HydroMax' on Aug. 21. Brief Summary: FHAME i... Read More
U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07151157) titled 'Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease' on Aug. 24. Brie... Read More
U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07151586) titled 'Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations... Read More